AspenTech at IFPAC 2022: Accelerate Digitalization Across Your Pharma Value Chain Network
Recent pandemic and drug recall events have highlighted the need to transform the pharma supply chain for greater agility and resiliency. Along with the increase in complex drug modalities and the rise of targeted medicines, change is imperative to enhance the supply chain to quickly deliver high quality, safe and effective medicines to consumers.
The COVID-19 pandemic highlighted the need for agility and resiliency within the supply chain for pharmaceutical companies. It is clear that speed to market will remain a top business imperative as we move into the next normal for pharma.